Flunitrazepam (Rohypnol)

Safety Summary

Regulatory Status

Sources

These citations are the ones recorded for the human adult context.

• US DEA: Flunitrazepam (Rohypnol) — Schedule IV Classification, Drug-Facilitated Sexual Assault Profile, Blue Dye Reformulation (1990s), Detection Window and GC-MS Testing Requirements, and US Import Prohibition (2022) REGULATORY · 2022
• SAMHSA: Drug-Facilitated Sexual Assault — Flunitrazepam, GHB, and Other Substances; Victim Presentation, Forensic Evidence Collection, Urine/Blood Testing Protocols, Adolescent Victim Demographics, and Clinical Recognition Guidelines (2019) REGULATORY · 2019
• 21 CFR part 1308 (eCFR versioner full XML, up to date as of 2026-09-25) REGULATORY
• OEHHA Proposition 65 List of Carcinogens or Reproductive Toxicants (CSV, list date 31-Jul-26) REGULATORY
• Permissible Exposure Limits – OSHA Annotated Table Z-1 REGULATORY
• EPA CompTox CTX API: predicted properties for DTXSID7023065 (Flunitrazepam (Rohypnol)) REFERENCE

Same data as the API response, which is open and needs no key. The full per-record source list is available to authenticated callers.